The Patent Finder
EB

Evaxion Biotech A/S

First filing 2013
OverviewNotableFeesChangesFamiliesPatent listSources & methods

15 patents currently held

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2032. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2032
Next term end
8
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 21, 2027
    The maintenance fee for Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus (US 9,085,631) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Vaccines targeting Pseudomonas aeruginosa (US 11,718,648) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 1 fee due Apr 8, 2027
    The maintenance fee for Proteins and nucleic acids useful in vaccines targeting Klebsiella Pneumoniae (US 10,434,162) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
  • 1 fee due May 7, 2027
    The maintenance fee for Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus (US 11,807,669) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Peptides derived from Acinetobacter Baumannii and their use in vaccination (US 11,857,615) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 9,085,631Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
In force
 · High confidence
In forceHigh confidence
US 9,534,022Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
In force
 · High confidence
In forceHigh confidence
US 10,034,928Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
In force
 · High confidence
In forceHigh confidence
US 10,675,340Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
In force
 · High confidence
In forceHigh confidence
US 11,052,145Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
In force
 · High confidence
In forceHigh confidence
US 11,807,669Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
In force
 · High confidence
In forceHigh confidence
US 11,857,615Peptides derived from Acinetobacter Baumannii and their use in vaccination
In force
 · Medium confidence
In forceMedium confidence
US 10,434,162Proteins and nucleic acids useful in vaccines targeting Klebsiella Pneumoniae
In force
 · High confidence
In forceHigh confidence
US 10,849,968Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
In force
 · High confidence
In forceHigh confidence
US 12,226,469Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
In force
 · High confidence
In forceHigh confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
Also on record, not counted in the 15: 2 patents in force now held by others · 16 applications pending · 6 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited